Some animal models suggested that kefir might have a potential to benefit the management of MetS by reducing body weight, fasting blood glucose, insulin, total, and LDL cholesterol, triacylglycerol, and pro–inflammatory cytokines, including IL–1β and IL–6 [38]. This evidence concerns the gene IL6 and metabolic syndrome.